article thumbnail

Leading API chemical companies in contract marketing

Pharmaceutical Technology

Various factors have contributed to the need and growth of API chemical suppliers such as rising healthcare expenditure, increasing disposable incomes, growing geriatric population, increasing incidence of chronic diseases, patent expiration of blockbuster drugs, increased consumption of generic drugs, and intervention of the new generation APIs.

Marketing 130
article thumbnail

Leading retail pharmacies in pharma

Pharmaceutical Technology

Prescription refill and generic drug programmes. The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision. . ยท Compounding services. Pharmacogenetics testing. Filling services. Prescription collection lockers.

Pharmacy 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves First Generic of Symbicort to Treat Asthma and COPD

The Pharma Data

Agency Supports Development of Complex Generic Drug-Device Combination Product to Improve Competition and Access to More Affordable Medicines. This complex generic drug-device combination product, which is a metered-dose inhaler, should not be used to treat acute asthma attacks. Today, the U.S.

article thumbnail

Proposed amendments to the PM(NOC) Regulations: Patents claiming different salt forms of medicinal ingredients eligible for inclusion on the Patent Register

Pharma in Brief

As previously reported , the Proposed FDR Amendments were intended to clarify the regulatory requirements under the Abbreviated New Drug Submission (โ€œ ANDS โ€) pathway for generic drug products that contain different forms (e.g.,

article thumbnail

OPQโ€™s 2023 Annual Report: an Upbeat Review of CDERโ€™s Quality Efforts

FDA Law Blog

This yearโ€™s report noted that CDERโ€™s Drug Product Catalog contains over 140,000 entries, the same amount as OPQ listed in 2022. In a display of the competition within the generic industry that keeps margins low , this total included 118 new drug applications and 956 generic drug applications.

article thumbnail

In the News: September 2021 Regulatory and Development Updates

Camargo

Appellate Court Ruling Impacts Orphan Drug Exclusivity. On September 30, the Eleventh Circuit Court of Appeals issued a decision reversing a district court ruling in a case involving orphan drug exclusivity. Container-closure changes. The guidance lists questions and answers for the following topics: Bracketing/matrixing.

article thumbnail

In the News: October Regulatory and Development Updates

Camargo

The FDA recently issued the guidance โ€œ Referencing Approved Drug Products in ANDA Submissions ,โ€ clarifying the use of the RLD and reference standard (RS) in an ANDA submission and defining which to reference in the basis of the submission.